 |
Polyethylene glycol-modified uricase |
|---|---|
| Trade Name | Zurase |
| Orphan Indication | Tumor lysis syndrome in cancer patients undergoing chemotherapy |
| USA Market Approval | USA |
| USA Designation Date | 1998-12-21 00:00:00 |
| Sponsor | EnzymeRx, LLC;17 Arcadian Avenue, Suite 104;Paramus, New Jersey, 07652 |
